This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (80)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Creating Consumer Demand

Matthew F. Hollon, MD

JAMA. 1999;281:382-384.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the early 1980s, the pharmaceutical industry began marketing prescription drugs directly to patients. The Food and Drug Administration (FDA) imposed a moratorium on this marketing strategy in 1983, then lifted it in 1985.¹ Since then, the industry has devoted increasing resources to this strategy. In a 1988 editorial on direct-to-consumer (DTC) marketing, Eric P. Cohen, MD, wrote, "Issues of regulation of advertising, cost, competition, public health, and individual well being need to be carefully examined."² Examination of these issues in rigorous, independent studies has not occurred. Despite the lack of studies, the FDA has relaxed regulations governing DTC marketing of prescription drugs.³

Proponents hypothesize that DTC marketing, by providing educational information, is valuable, notifying consumers of new therapies and motivating them to seek care. However, the pharmaceutical industry, driven in part by financial motives, is providing information of suspect quality and thus minimal benefit. Reckoning . . . [Full Text of this Article]

Author Affiliation: Dr Hollon is Fellow, Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Direct-to-Consumer Prescription Drug Advertising Builds Bridges Between Patients and Physicians
Alan F. Holmer
JAMA. 1999;281(4):380-382.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report
Parnes et al.
Ann Fam Med 2009;7:41-46.
ABSTRACT | FULL TEXT  

Race, religion, and informed consent - lessons from social science.
Matthew
J Law Med Ethics 2008;36:150-173.
 

News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory
Hartley and Coleman
Health (London) 2008;12:107-132.
ABSTRACT  

Direct-To-Consumer Advertisements For HIV Antiretroviral Medications: A Progress Report
Kallen et al.
Health Aff (Millwood) 2007;26:1392-1398.
ABSTRACT | FULL TEXT  

Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising
Frosch et al.
Ann Fam Med 2007;5:6-13.
ABSTRACT | FULL TEXT  

Autonomy, consent, and limiting healthcare costs
Graber and Tansey
J. Med. Ethics 2005;31:424-426.
ABSTRACT | FULL TEXT  

Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial
Kravitz et al.
JAMA 2005;293:1995-2002.
ABSTRACT | FULL TEXT  

Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion
Hollon
JAMA 2005;293:2030-2033.
FULL TEXT  

Advertising by Academic Medical Centers
Larson et al.
Arch Intern Med 2005;165:645-651.
ABSTRACT | FULL TEXT  

The Third-Person Effect and its Influence on Behavioral Outcomes in a Product Advertising Context:: The Case of Direct-to-Consumer Prescription Drug Advertising
Huh et al.
Communication Research 2004;31:568-599.
ABSTRACT  

Direct-to-Consumer Advertising: Public Perceptions of Its Effects on Health Behaviors, Health Care, and the Doctor-Patient Relationship
Murray et al.
J Am Board Fam Med 2004;17:6-18.
ABSTRACT | FULL TEXT  

Direct-to-Consumer Advertising: Physicians' Views of Its Effects on Quality of Care and the Doctor-Patient Relationship
Murray et al.
J Am Board Fam Med 2003;16:513-524.
ABSTRACT | FULL TEXT  

Knowledge and Attitudes Regarding Cardiovascular Disease Risk and Prevention in Patients With Coronary or Peripheral Arterial Disease
McDermott et al.
Arch Intern Med 2003;163:2157-2162.
ABSTRACT | FULL TEXT  

Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer Beware
Gray and Olopade
JCO 2003;21:3191-3193.
FULL TEXT  

Clinicians' Responses to Direct-to-Consumer Advertising of Prescription Medications
Zachry et al.
Arch Intern Med 2003;163:1808-1812.
ABSTRACT | FULL TEXT  

Direct-to-Consumer Marketing of Osteoporosis Drugs and Bone Densitometry
Hollon et al.
The Annals of Pharmacotherapy 2003;37:976-981.
ABSTRACT | FULL TEXT  

Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing
Gollust et al.
JAMA 2002;288:1762-1767.
ABSTRACT | FULL TEXT  

The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United States
Huang
JAMA 2000;284:2240-2240.
FULL TEXT  

Clopidogrel and Thrombotic Thrombocytopenic Purpura
Salliere et al.
NEJM 2000;343:1191-1194.
FULL TEXT  

Accutane(R)-Exposed Pregnancies--California, 1999
Arch Dermatol 2000;136:686-687.
FULL TEXT  

Direct-to-Consumer Advertising: Education or Anathema?
Alper et al.
JAMA 1999;282:1226-1228.
FULL TEXT